Oversea-Chinese Banking Corporation (OCBC) is gaining momentum in its post-pandemic recovery, with analysts across six research houses recommending “buy” or “add” on the bank. 

RHB Group Research upgraded OCBC to “buy” from “neutral” with a higher target price of $12.50 from $9.50.

“Sustained q-o-q improvements in operations and asset quality, underpinned by the re-opening of regional economies, have led to a more optimistic guidance on credit cost and loan growth. Our revised earnings estimates point to a healthy return on equity (ROE) recovery, while its robust capital provides room for higher dividends further ahead. These, we believe, will support a share price re-rating. Our target price reflects 1.05 times price to book value (P/BV),” notes RHB. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook